Crossmark

Lipoprotein levels and statin treatment related to dementia and cognitive decline in individuals with type 2 diabetes: an observational analysis from the ADVANCE study

Crossref DOI link: https://doi.org/10.1186/s12933-025-02894-3

Published Online: 2025-08-18

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

af Geijerstam, Peder https://orcid.org/0000-0001-6038-5131
Chalmers, John https://orcid.org/0000-0002-9931-0580
Pikkemaat, Miriam https://orcid.org/0000-0002-9808-207X
Peters, Ruth https://orcid.org/0000-0003-0148-3617
Marre, Michel https://orcid.org/0000-0002-3071-1837
Mancia, Giuseppe https://orcid.org/0000-0003-0942-3176
Woodward, Mark https://orcid.org/0000-0001-9800-5296
Harris, Katie https://orcid.org/0000-0003-2444-2869
Funding

Funding for this research was provided by:

Linköping University
License Information

Text and Data Mining valid from 2025-08-18

Version of Record valid from 2025-08-18
More Information

Article History

Received: 3 June 2025

Accepted: 4 August 2025

First Online: 18 August 2025

Declarations

:

: The authors declare no competing interests.